Apricus Biosciences (NASDAQ:APRI)

CAPS Rating: 1 out of 5

A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.

Caps

How do you think APRI will perform against the market?

Add Stock to CAPS Watchlist

All Players

57 Outperform
21 Underperform
 

All-Star Players

3 Outperform
14 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top APRI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

qualatech (59.42)
Submitted October 23, 2013

Just received approval for phase testing of ED drug in Europe. Much insider ownership. Little debt. Just registered 1M shares. Management knows something the street doesnt.

zzlangerhans (99.80)
Submitted February 08, 2015

In January Apricus showed signs of life after a steady six month decline in share price from the 2's. A sharp spike from the lows followed by pullback and consolidation seemed to suggest another move upward would be forthcoming. I flagged that green… More

APRI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about APRI.

Recs

0
Member Avatar urmoney (99.78) Submitted: 6/21/2017 3:56:39 PM : Underperform Start Price: $1.00 APRI Score: -49.09

cause he said so

Recs

0
Member Avatar SmartAce (99.94) Submitted: 6/21/2017 2:59:20 PM : Underperform Start Price: $1.00 APRI Score: -49.20

If Sesame Street really cared about children they'd realize Big Bird could feed a hungry family for a month.

Recs

1
Member Avatar qualatech (59.42) Submitted: 10/23/2013 2:55:06 PM : Outperform Start Price: $20.30 APRI Score: -131.63

Just received approval for phase testing of ED drug in Europe. Much insider ownership. Little debt. Just registered 1M shares. Management knows something the street doesnt.

Leaderboard

Find the members with the highest scoring picks in APRI.

Score Leader

kaleidescopic

kaleidescopic (< 20) Score: +201.99

The Score Leader is the player with the highest score across all their picks in APRI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kaleidescopic < 20 9/2/2011 Underperform 5Y $50.20 -97.03% +104.96% +201.99 0 Comment
Troy2008 93.28 11/23/2011 Underperform 5Y $41.50 -96.41% +105.56% +201.97 0 Comment
GoOtto4Nic8 < 20 11/15/2011 Underperform 5Y $43.30 -96.56% +93.90% +190.46 1 Comment
cemkaner < 20 7/14/2011 Underperform 1Y $49.60 -97.00% +83.63% +180.63 0 Comment
mickmcmahon < 20 6/25/2012 Underperform 5Y $34.50 -95.68% +84.72% +180.41 0 Comment
cecamadocv4 99.95 2/16/2011 Underperform 5Y $39.90 -96.27% +81.18% +177.45 0 Comment
allstar31 99.86 3/6/2012 Underperform 5Y $31.45 -95.26% +79.32% +174.58 1 Comment
WPaulFin < 20 6/29/2007 Underperform 1Y $271.50 -99.45% +69.56% +169.02 0 Comment
JustAsWell 97.45 5/25/2007 Underperform NS $265.50 -99.44% +68.88% +168.32 0 Comment
headyinvestor 84.78 9/7/2012 Underperform 5Y $29.20 -94.90% +68.54% +163.43 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJMP 82.82 6/14/2012 Outperform NS $30.90 -95.18% +83.40% -178.58 0 Comment
TrackRothCapital 67.96 6/6/2012 Outperform NS $25.00 -94.04% +86.74% -180.78 0 Comment
TrackDawsonJames < 20 12/14/2010 Outperform NS $36.00 -95.86% +94.56% -190.42 0 Comment
TrackRothCapital 67.96 7/20/2010 Outperform NS $32.20 +68.63% +27.89% +40.74 5/3/2011 @ $54.30 0 Comment
TrackOppenheimer 64.36 2/14/2008 Outperform NS $225.00 -99.34% +84.70% -184.04 0 Comment
TrackBreanMurray 77.82 7/9/2007 Outperform NS $260.85 -99.43% +66.95% -166.38 0 Comment

Featured Broker Partners